Bromhidrosis Disease Treatment Market Size to Grow by 362.76 Mn, Increasing Number of M&A by Vendors to be a Key Trend

0
76
Bromhidrosis Disease Treatment Market Size to Grow by 362.76 Mn, Increasing Number of M&A by Vendors to be a Key Trend


NEW YORK, Nov. 9, 2022 /PRNewswire/ — The bromhidrosis disease treatment market size is expected to grow by USD 362.76 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 8.92% during the forecast period, according to Technavio. The market has been segmented by type geography (North America, Europe, Asia, and Rest of World (ROW) and (apocrine body odor and eccrine body odor). Get a comprehensive report summary that describes the market size and forecast along with research methodology. The FREE sample report is available in PDF format

Technavio has announced its latest market research report titled Global Bromhidrosis Disease Treatment Market 2022-2026

Technavio has announced its latest market research report titled Global Bromhidrosis Disease Treatment Market 2022-2026

The rise in the number of patients affected by diabetes and kidney diseases, government awareness programs about the disease, and an increase in healthcare affordability in the US are some of the major factors propelling the market growth. However, factors such as the high cost of treatment, rise in the cost of R&D activities, and lack of knowledge of the disease will hamper the market growth.

More details: https://www.technavio.com/report/bromhidrosis-disease-treatment-market-industry-analysis

Bromhidrosis Disease Treatment Market: Trend

The increasing M&As is a key trend shaping the bromhidrosis disease treatment market. The key vendors are acquiring small vendors to gain access to new products and technologies at low costs. For instance, in February 2022, Ipsen Pharma partnered with Mayoly Spindler to sell its global consumer healthcare business. In May 2022, Pfizer Inc. announced the acquisition of Biohaven Pharmaceutical Holding Company Ltd. In January 2022, Novartis AG partnered with Alnylam to work on targeted therapy to restore liver function. Thus, the rise in the number of M&A will support the growth of the market in the coming years.

Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. Buy Now for detailed information about market dynamics

Bromhidrosis Disease Treatment Market: Type Landscape

By type, the apocrine body odor segment will be a significant contributor to market growth during the forecast period. Apocrine sweat, when discharged, is colorless and odorless. In apocrine bromhidrosis, body odor is caused due to the combination of lipid-rich apocrine gland perspiration with microorganisms on the skin. This leads to the formation of thioalcohol. Thus, the increase in the number of people with apocrine bromhidrosis will drive the growth of the segment during the forecast period.

Bromhidrosis Disease Treatment Market: Geographic Landscape

By geography, North America is going to have lucrative growth during the forecast period. About 38% of the market’s overall growth is expected to originate from the region. The US and Canada are the key markets for bromhidrosis disease treatment in North America. The growth of the market in the region is attributed to factors such as rising healthcare expenditures, a well-developed healthcare sector, a large patient population, and government backing for R&D.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

Bromhidrosis Disease Treatment Market: Companies Covered

  • AbbVie Inc. – The company offers bromhidrosis disease treatment, namely Botox.

  • Galderma SA – The company offers bromhidrosis disease treatment, namely Alluzience.

  • Hikma Pharmaceuticals Plc – The company offers bromhidrosis disease treatment, namely Glycopyrrolate injection.

  • Ipsen Pharma – The company offers bromhidrosis disease treatment, namely Dysport.

  • Biovencer Healthcare Pvt. Ltd.

  • Johnson & Johnson – The company offers bromhidrosis disease treatment, namely Ditropan XL, through its subsidiary Janssen.

  • Boehringer Ingelheim International GmbH

  • Journey Medical Corp.

  • Medytox Inc.

  • Merz Pharma GmbH & Co. KGaA

  • Novartis AG

  • Pfizer Inc.

Bromhidrosis Disease Treatment Market: What our reports offer

  • Market share assessments for the regional and country-level segments

  • Strategic recommendations for the new entrants

  • Covers market data from 2021 to 2026

  • Market trends (threats, challenges, drivers, investment opportunities, and recommendations)

  • Strategic recommendations in key business segments based on the market estimations

  • Competitive landscaping recording the key common trends

  • Company profiling with financials, detailed strategies, and recent developments

  • Supply chain trends mapping the latest technological advancements

Get lifetime access to our Technavio Insights! Subscribe to our Basic Plan billed annually at USD 5000

Related Reports

Gastrointestinal Diseases Therapeutics Market by Drug Class and Geography – Forecast and Analysis 2022-2026: The increasing incidence of gastrointestinal diseases is driving market growth. Gastrointestinal diseases have increased significantly across the globe. Improper diet, inactive lifestyle, stress, food sensitivity, and bacterial or viral infection are the major factors contributing to the increasing incidence of chronic and acute gastrointestinal diseases.

Celiac Diseases Drugs Market by Therapy Type and Geography – Forecast and Analysis 2022-2026: Higher consumption of gluten-containing food is driving the market growth. Celiac disease is characterized by an increase in gluten deposition in the body due to the high consumption of food containing gluten. Pizza, cake, soups, beer, bread, cookies, pasta, and burgers are some of the widely consumed food that contains gluten.

Bromhidrosis Disease Treatment Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 8.92%

Market growth 2022-2026

USD 362.76 million

Market structure

Concentrated

YoY growth (%)

6.99

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key consumer countries

US, Canada, Germany, UK, China, US, Canada, Germany, UK, China, US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

AbbVie Inc., Biovencer Healthcare Pvt. Ltd., Boehringer Ingelheim International GmbH, Galderma SA, Hikma Pharmaceuticals Plc, Ipsen Pharma, Johnson & Johnson, Journey Medical Corp., Medytox Inc., Merz Pharma GmbH & Co. KGaA, Novartis AG, and Pfizer Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Type

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Global Bromhidrosis Disease Treatment Market 2022-2026

Global Bromhidrosis Disease Treatment Market 2022-2026

Cision

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/bromhidrosis-disease-treatment-market-size-to-grow-by-362-76-mn-increasing-number-of-ma-by-vendors-to-be-a-key-trend—technavio-301671304.html

SOURCE Technavio



Source link